Varex Imaging (VREX) Projected to Post Earnings on Tuesday

Varex Imaging (NASDAQ:VREX) is expected to issue its Q1 2026 results after the market closes on Tuesday, February 10th. Analysts expect the company to announce earnings of $0.14 per share and revenue of $207.8250 million for the quarter. Varex Imaging has set its Q1 2026 guidance at 0.050-0.250 EPS. Individuals may visit the the company’s upcoming Q1 2026 earning results page for the latest details on the call scheduled for Tuesday, February 10, 2026 at 5:00 PM ET.

Varex Imaging (NASDAQ:VREX) last released its quarterly earnings data on Tuesday, November 18th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.19. The company had revenue of $228.90 million for the quarter, compared to analyst estimates of $219.26 million. Varex Imaging had a positive return on equity of 7.19% and a negative net margin of 8.32%. On average, analysts expect Varex Imaging to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Varex Imaging Price Performance

Shares of VREX stock opened at $14.00 on Monday. The stock’s fifty day simple moving average is $12.74 and its 200 day simple moving average is $11.65. Varex Imaging has a one year low of $6.76 and a one year high of $14.56. The firm has a market cap of $586.88 million, a price-to-earnings ratio of -8.24 and a beta of 0.90. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.43 and a quick ratio of 1.83.

Analysts Set New Price Targets

Several brokerages have recently commented on VREX. Weiss Ratings restated a “sell (d-)” rating on shares of Varex Imaging in a research note on Monday, December 29th. Jefferies Financial Group reaffirmed a “hold” rating and set a $14.50 price objective on shares of Varex Imaging in a research note on Monday, February 2nd. Wall Street Zen raised shares of Varex Imaging from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 22nd. B. Riley Financial restated a “buy” rating and set a $16.00 price target on shares of Varex Imaging in a research report on Wednesday, November 19th. Finally, Oppenheimer reduced their price objective on Varex Imaging from $23.00 to $18.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 19th. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Varex Imaging has an average rating of “Hold” and an average price target of $16.17.

Institutional Trading of Varex Imaging

A number of institutional investors have recently bought and sold shares of the business. The Manufacturers Life Insurance Company boosted its position in shares of Varex Imaging by 10.4% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,302 shares of the company’s stock worth $133,000 after purchasing an additional 1,442 shares during the last quarter. Comerica Bank boosted its holdings in Varex Imaging by 9.3% during the third quarter. Comerica Bank now owns 20,363 shares of the company’s stock worth $253,000 after buying an additional 1,726 shares during the last quarter. BNP Paribas Financial Markets raised its position in shares of Varex Imaging by 18.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock valued at $113,000 after acquiring an additional 2,036 shares during the period. Nebula Research & Development LLC boosted its stake in Varex Imaging by 11.0% during the 2nd quarter. Nebula Research & Development LLC now owns 22,795 shares of the company’s stock worth $198,000 after acquiring an additional 2,250 shares during the last quarter. Finally, Rhumbline Advisers grew its holdings in Varex Imaging by 4.6% during the second quarter. Rhumbline Advisers now owns 61,820 shares of the company’s stock valued at $536,000 after purchasing an additional 2,694 shares during the period.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.